Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide pens used for weight loss contain multiple pre-measured doses designed to support gradual dose escalation over time. Understanding pen capacity and dose delivery helps patients manage their GLP-1 therapy with confidence. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, removing the complexity of insurance requirements while maintaining pharmaceutical-grade quality from licensed 503A compounding pharmacies.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Many Doses Fit Inside a Semaglutide Pen
A standard semaglutide pen contains four separate doses delivered across weekly injections. Each dose is pre-filled and measured to eliminate guesswork during administration. This four-dose design aligns with the typical one-month treatment window, allowing patients to complete a full cycle before obtaining a new pen.
The pen mechanism uses a dial system that advances with each injection, ensuring precise dose delivery. Patients turn the dial to select their prescribed dose strength, and the pen automatically measures the correct volume. This design has made semaglutide one of the most accessible injectable medications for patients new to self-administered therapies.
Understanding Dose Progression in Semaglutide Treatment
Semaglutide therapy typically begins at a low starting dose and increases gradually over several weeks to minimize gastrointestinal side effects and allow the body to adapt. A standard titration schedule involves four weekly injections before advancing to the next dose level, which is why pen capacity matches this progression perfectly. This stepped approach has been shown to improve treatment tolerance and long-term adherence rates.
Each dose increase represents a meaningful step in therapeutic intensity, and the four-dose pen format naturally supports this escalation timeline. Patients moving through their first month experience the initial 0.25mg dose, while subsequent months progress through 0.5mg, 1.0mg, and eventually maintenance doses of 2.0mg or higher depending on individual response and clinical goals.
Compounded Semaglutide vs. Brand-Name Pen Delivery
PlexusDx compounded semaglutide injections offer flexibility that brand-name pens sometimes cannot match. While brand pens come pre-filled with fixed dose increments, compounded formulations can be customized to match individual patient needs across the full range of therapeutic doses. This personalization removes the constraint of waiting for specific dose strengths to become available.
Compounded semaglutide from licensed 503A compounding pharmacies meets the same manufacturing standards as brand medications while offering cost savings and accessibility. PlexusDx customers pay a flat monthly rate at $189/mo month-to-month, or from $149/mo on the 6-month plan—your dose may need to go up, but your price won't. All formulations are HSA/FSA eligible, and no insurance verification or membership fee is required to access treatment across all 50 states.
Tracking Your Dose Schedule and Pen Usage
Keeping a simple record of injection dates and dose levels helps patients monitor their progress and communicate clearly with their healthcare provider. Many patients benefit from marking their calendar or using phone reminders for weekly injection days, especially during the dose escalation phase. This consistency supports optimal results and makes it easier to spot any patterns related to side effects or appetite changes.
PlexusDx patients have access to digital tools and clinical support teams who can help coordinate dose timing with individual schedules. Whether you're advancing through the titration phase or maintaining a stable dose, consistent weekly administration on the same day of the week simplifies routine and improves treatment outcomes. If you're interested in understanding how your genetic makeup influences peptide response, the Precision Peptide Genetic Test can identify key variants affecting semaglutide efficacy.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
How many weeks does one semaglutide pen last?
One semaglutide pen contains four weekly doses, so it typically lasts one month or approximately four weeks. If you're on a maintenance dose that uses more than one injection per week, your pen may last less than one month. PlexusDx can coordinate your refill schedule to match your actual dosing frequency.
What happens if I run out of medication between pen refills?
Running out of semaglutide mid-cycle is uncommon when following a standard titration schedule, but it can happen if doses increase faster than expected or refills are delayed. Contact your PlexusDx care team immediately for guidance—they can coordinate expedited refills or temporary dose adjustments to maintain continuity of your treatment plan.
Can I adjust my weekly injection schedule if needed?
Most patients benefit from consistent weekly injections on the same day, but PlexusDx clinicians can discuss schedule modifications based on your lifestyle and treatment goals. Any changes to timing or frequency should be coordinated with your care team to ensure continued effectiveness and safety.
Does PlexusDx charge different prices for different dose levels?
No. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of your dose strength. Your dose may need to go up as your body adjusts to treatment, but your price remains flat—there are no surprise increases tied to higher dose levels.
How does genetic testing improve my semaglutide outcomes?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Which GLP-1 is Right for Me? Exploring Your Options
Understanding the Cost of Semaglutide for Weight Loss